LeafNLP Demos
Back to explore

Report #2886404

Received Feb 23, 2026

Reports are unverified and do not show that a vaccine caused an event. Full disclaimer

Overview

Sex
Unknown
Age
Age unknown
State
CO
Recovered
Unknown
Vaccinated
Dec 17, 2025
Onset
Dec 17, 2025
Days to onset
0
Hospital days
—

Vaccines (2)

TypeNameManufacturerDoseLotRoute / Site
MMRVMEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD)MERCK & CO. INC.UNKZ010731—
VARCELVARICELLA (VARIVAX)MERCK & CO. INC.UNKZ008083—

Symptoms (2)

Extra dose administeredNo adverse event

Symptom narrative

No additional AE; a patient was administered PROQUAD and VARIVAX concomitantly on 12/17/2025.; This Spontaneous report was received from Nurse and referred to a patient of unknown age and gender. The patient's medical history was not reported. The patient's past medications were not reported. The patient's concomitant medications were not reported. On 17-Dec-2025, the patient was vaccinated with Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live lyophilisate and solvent for solution for injection (1 dose, Lot Number: Z010731, Expiration date: 22-Dec-2026; strength, frequency and route were not reported) and Varicella Virus Vaccine Live (Oka-Merck) lyophilisate and solvent for solution for injection (1 dose, Batch/Lot Number: Z008083, Expiration date: 28-Apr-2027; strength, frequency and route were not reported) concomitantly for Prophylaxis (Overdose). No additional adverse event (AE)/no product quality complaints (PQC) reported.

Other medications

DILUENT